135 related articles for article (PubMed ID: 22178219)
21. High-frequency minisatellite instability of the mitochondrial genome in colorectal cancer tissue associated with clinicopathological values.
Lim SW; Kim HR; Kim HY; Huh JW; Kim YJ; Shin JH; Suh SP; Ryang DW; Kim HR; Shin MG
Int J Cancer; 2012 Sep; 131(6):1332-41. PubMed ID: 22120612
[TBL] [Abstract][Full Text] [Related]
22. Somatic mutations of mitochondrial DNA in digestive tract cancers.
Kose K; Hiyama T; Tanaka S; Yoshihara M; Yasui W; Chayama K
J Gastroenterol Hepatol; 2005 Nov; 20(11):1679-84. PubMed ID: 16246185
[TBL] [Abstract][Full Text] [Related]
23. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis.
Alonso A; Martin P; Albarran C; Aquilera B; Garcia O; Guzman A; Oliva H; Sancho M
Electrophoresis; 1997 May; 18(5):682-5. PubMed ID: 9194590
[TBL] [Abstract][Full Text] [Related]
24. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.
Yeh JJ; Lunetta KL; van Orsouw NJ; Moore FD; Mutter GL; Vijg J; Dahia PL; Eng C
Oncogene; 2000 Apr; 19(16):2060-6. PubMed ID: 10803467
[TBL] [Abstract][Full Text] [Related]
25. Somatic mutations of the mitochondrial genome in Chinese patients with Ewing sarcoma.
Yu M; Wan Y; Zou Q
Hum Pathol; 2013 Jul; 44(7):1350-6. PubMed ID: 23375644
[TBL] [Abstract][Full Text] [Related]
26. [Roles of mitochondrial DNA somatic mutations in the pathogenesis of benign breast disease: a perspective from whole genome study].
Yang Y; Mei S; He JD; Guo XJ; Che YH; Zhang Y; Li L
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2394-7. PubMed ID: 23158660
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
28. Analysis of potential cancer biomarkers in mitochondrial DNA.
Jakupciak JP; Dakubo GD; Maragh S; Parr RL
Curr Opin Mol Ther; 2006 Dec; 8(6):500-6. PubMed ID: 17243485
[TBL] [Abstract][Full Text] [Related]
29. Complete mitochondrial DNA sequence analysis of Bison bison and bison-cattle hybrids: function and phylogeny.
Douglas KC; Halbert ND; Kolenda C; Childers C; Hunter DL; Derr JN
Mitochondrion; 2011 Jan; 11(1):166-75. PubMed ID: 20870040
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial DNA mutations in human disease.
Greaves LC; Taylor RW
IUBMB Life; 2006 Mar; 58(3):143-51. PubMed ID: 16766381
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous DNA and RNA Mapping of Somatic Mitochondrial Mutations across Diverse Human Cancers.
Stewart JB; Alaei-Mahabadi B; Sabarinathan R; Samuelsson T; Gorodkin J; Gustafsson CM; Larsson E
PLoS Genet; 2015 Jun; 11(6):e1005333. PubMed ID: 26125550
[TBL] [Abstract][Full Text] [Related]
32. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma.
Kumimoto H; Yamane Y; Nishimoto Y; Fukami H; Shinoda M; Hatooka S; Ishizaki K
Int J Cancer; 2004 Jan; 108(2):228-31. PubMed ID: 14639607
[TBL] [Abstract][Full Text] [Related]
33. Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
Shuwen H; Xi Y; Yuefen P
Dis Markers; 2017; 2017():5189803. PubMed ID: 28408773
[TBL] [Abstract][Full Text] [Related]
34. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.
van Gisbergen MW; Voets AM; Starmans MH; de Coo IF; Yadak R; Hoffmann RF; Boutros PC; Smeets HJ; Dubois L; Lambin P
Mutat Res Rev Mutat Res; 2015; 764():16-30. PubMed ID: 26041263
[TBL] [Abstract][Full Text] [Related]
35. Complexities and pitfalls in analyzing and interpreting mitochondrial DNA content in human cancer.
Nguyen H; LaFramboise T
J Genet Genomics; 2020 Jul; 47(7):349-359. PubMed ID: 33004308
[TBL] [Abstract][Full Text] [Related]
36. Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs.
Ohta S
Oncogene; 2006 Aug; 25(34):4768-76. PubMed ID: 16892089
[TBL] [Abstract][Full Text] [Related]
37. Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients.
Wang CY; Li H; Hao XD; Liu J; Wang JX; Wang WZ; Kong QP; Zhang YP
PLoS One; 2011; 6(6):e21613. PubMed ID: 21738732
[TBL] [Abstract][Full Text] [Related]
38. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip.
Lévêque M; Marlin S; Jonard L; Procaccio V; Reynier P; Amati-Bonneau P; Baulande S; Pierron D; Lacombe D; Duriez F; Francannet C; Mom T; Journel H; Catros H; Drouin-Garraud V; Obstoy MF; Dollfus H; Eliot MM; Faivre L; Duvillard C; Couderc R; Garabedian EN; Petit C; Feldmann D; Denoyelle F
Eur J Hum Genet; 2007 Nov; 15(11):1145-55. PubMed ID: 17637808
[TBL] [Abstract][Full Text] [Related]
39. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
[TBL] [Abstract][Full Text] [Related]
40. Deciphering the signature of selective constraints on cancerous mitochondrial genome.
Liu J; Wang LD; Sun YB; Li EM; Xu LY; Zhang YP; Yao YG; Kong QP
Mol Biol Evol; 2012 Apr; 29(4):1255-61. PubMed ID: 22130971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
